Scadden David (CIK 0001707715)

Latest company ownership

Shares held
773,998
Last filed at
Jun 20, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
200
Last filed at
Nov 14, 2025
Confidence Score
44.6
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 12, 2025 Nov 14, 2025 AGIOS PHARMACEUTICALS, INC. Director Sell 50.0 -200 -1.12% ✓ $8.8K
Oct 8, 2025 Oct 10, 2025 AGIOS PHARMACEUTICALS, INC. Director Sell 50.0 -200 -1.12% ✓ $8.2K
Sep 30, 2025 Oct 2, 2025 AGIOS PHARMACEUTICALS, INC. Director Sell 50.0 -200 -1.12% ✓ $8K
Aug 27, 2025 Aug 29, 2025 AGIOS PHARMACEUTICALS, INC. Director Sell 50.0 -200 -1.12% ✓ $8K
Jul 10, 2025 Jul 15, 2025 AGIOS PHARMACEUTICALS, INC. Director Sell 32.5 -1,400 -7.37% ✓ $56K
Dec 11, 2024 Dec 13, 2024 AGIOS PHARMACEUTICALS, INC. Director Sell 50.0 -200 -1.28% ✓ $9.3K
Jun 25, 2018 Jun 27, 2018 Dianthus Therapeutics, Inc. /DE/ Director Buy 72.5 +6,600 0.82% ✗ $99K
Mar 16, 2018 Mar 20, 2018 AGIOS PHARMACEUTICALS, INC. Director Buy 91.3 +200 53.91% ✗ $16.7K